The Roberts Glore & Co. Inc. IL Acquires Shares of 6,095 Cerner Corp. (CERN)

The Roberts Glore & Co. Inc. IL Acquires Shares of 6,095 Cerner Corp. (CERN)

Roberts Glore & Co. Inc. IL purchased a new position in Cerner Corp. (NASDAQ:CERN) during the second quarter, Holdings Channel reports. The institutional investor purchased 6,095 shares of the company’s stock, valued at approximately $357,000.

A number of other hedge funds also recently modified their holdings of the company. Loomis Sayles & Co. L P increased its stake in Cerner Corp. by 56.7% in the first quarter. Loomis Sayles & Co. L P now owns 6,953,349 shares of the company’s stock valued at $368,249,000 after buying an additional 2,517,398 shares during the period. Geode Capital Management LLC increased its stake in Cerner Corp. by 2.1% in the first quarter. Geode Capital Management LLC now owns 2,583,439 shares of the company’s stock valued at $136,554,000 after buying an additional 52,238 shares during the period. Scharf Investments LLC increased its stake in Cerner Corp. by 43.5% in the first quarter. Scharf Investments LLC now owns 2,101,147 shares of the company’s stock valued at $111,277,000 after buying an additional 637,168 shares during the period. Legal & General Group Plc increased its stake in Cerner Corp. by 3.9% in the first quarter. Legal & General Group Plc now owns 1,237,391 shares of the company’s stock valued at $65,533,000 after buying an additional 46,424 shares during the period. Finally, AXA increased its stake in Cerner Corp. by 4.1% in the first quarter. AXA now owns 1,115,509 shares of the company’s stock valued at $59,077,000 after buying an additional 43,780 shares during the period. Institutional investors own 81.41% of the company’s stock.

Shares of Cerner Corp. (NASDAQ:CERN) traded down 0.20% on Monday, hitting $60.83. The stock had a trading volume of 1,543,152 shares. The company has a market cap of $20.54 billion, a price-to-earnings ratio of 33.40 and a beta of 0.79. Cerner Corp. has a one year low of $49.59 and a one year high of $68.31. The firm’s 50-day moving average is $62.56 and its 200-day moving average is $59.39.

Cerner Corp. (NASDAQ:CERN) last released its quarterly earnings results on Tuesday, August 2nd. The company reported $0.58 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.57 by $0.01. The firm had revenue of $1.22 billion for the quarter, compared to the consensus estimate of $1.21 billion. Cerner Corp. had a return on equity of 18.57% and a net margin of 13.53%. The firm’s quarterly revenue was up 8.0% compared to the same quarter last year. During the same quarter last year, the business posted $0.52 EPS. On average, analysts expect that Cerner Corp. will post $2.36 EPS for the current fiscal year.

CERN has been the subject of several research analyst reports. Bank of America Corp. initiated coverage on Cerner Corp. in a research report on Monday, September 19th. They set a “neutral” rating and a $67.00 target price for the company. Zacks Investment Research upgraded Cerner Corp. from a “hold” rating to a “buy” rating and set a $69.00 price target on the stock in a research note on Tuesday, October 4th. Raymond James Financial Inc. lowered Cerner Corp. from an “outperform” rating to a “market perform” rating and set a $64.57 price target on the stock. in a research note on Tuesday, July 5th. Barclays PLC raised their price target on Cerner Corp. from $55.00 to $67.00 and gave the company an “overweight” rating in a research note on Wednesday, August 3rd. Finally, Oppenheimer Holdings Inc. restated an “outperform” rating and set a $67.00 price target on shares of Cerner Corp. in a research note on Friday. Ten equities research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Cerner Corp. presently has an average rating of “Buy” and an average price target of $66.35.

In related news, Director Linda M. Dillman sold 6,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 6th. The stock was sold at an average price of $64.68, for a total transaction of $388,080.00. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Vice Chairman Clifford W. Illig sold 325,705 shares of the firm’s stock in a transaction that occurred on Thursday, August 18th. The stock was sold at an average price of $65.10, for a total value of $21,203,395.50. Following the transaction, the insider now owns 6,652,392 shares in the company, valued at approximately $433,070,719.20. The disclosure for this sale can be found here. Corporate insiders own 13.20% of the company’s stock.

About Cerner Corp.

Cerner Corporation is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations. Its segments include Domestic and Global. The Domestic segment includes the business activity in the United States.

Related posts

Leave a Comment